Read-Gene (WAR:RDG) Cash Flow for Dividends : zł0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Read-Gene Cash Flow for Dividends?

Read-Gene's cash flow for dividends for the three months ended in Sep. 2023 was zł0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2023 was zł0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Read-Gene Cash Flow for Dividends Historical Data

The historical data trend for Read-Gene's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Read-Gene Cash Flow for Dividends Chart

Read-Gene Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash Flow for Dividends

Get a 7-Day Free Trial

Read-Gene Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Read-Gene Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00 Mil.

Read-Gene Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Read-Gene's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Read-Gene (WAR:RDG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Read-Gene SA (WAR:RDG) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ulica Alabastrowa 8, Grzepnica, Dobra, POL, 72-003

Website

http://www.read-gene.com

Read-Gene SA treats each patient individually based on genetic tests. The company's segments include chemoprevention, clinical trials and genetic tests. It also engaged in developing technologies to commercialize methods to detect, prevent and treat malignant tumours.

Read-Gene (WAR:RDG) Headlines

No Headlines